Summary
The product Equipoise Boldenone Undecylenate 250 mg/ml, manufactured by Vulkan Pharmaceuticals, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 2IU08C, was submitted by the manufacturer vulkanpharma@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Boldenone Undecylenate, with a concentration of 236.22 mg/ml, which is 5.51% below the labeled claim of 250 mg/ml.
The testing process was conducted on 13 November 2024. While the results indicate a slight underdosing, scrutiny of manufacturer-submitted samples is essential to ensure reliability. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Vulkan Pharmaceuticals
- Product Name: Equipoise Boldenone Undecylenate 250 mg/ml
- Active Ingredient: Boldenone Undecylenate
- Batch Number: 2IU08C
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #52531
- Testing Ordered: 29 OCT 2024
- Sample Received: 05 NOV 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Vulkan Pharmaceuticals (Manufacturer)
- Analysis Paid For By: Vulkan Pharmaceuticals (Manufacturer)
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 236.22 mg/ml
- Accuracy: 94.49% (5.51% below the label claim)
- Variance: -5.51%
Verification Details
- Verification URL: https://janoshik.com/tests/52531_FKHY9WSU87W2
Evaluation of Manufacturer-Submitted Testing
This analysis highlights a slight underdosing of the tested product, which warrants careful evaluation due to its submission by the manufacturer. Manufacturer-submitted samples may not always represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Boldenone Undecylenate 250 mg/ml is slightly underdosed, with a measured concentration of 236.22 mg/ml. This result reflects a minor deviation from the labeled claim and underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
